|
Characteristics
|
Delamanid is a new antituberculosis drug that inhibits mycolic acid synthesis and has shown potent in vitro and in vivo activity against drug-resistant strains of Mycobacterium tuberculosis.
|
|
Purity
|
99 % ee by HPLC and > 99 % by LC
|
|
Chemical Name
|
(2R)-2-Methyl-6-nitro-2-[(4-{4-[4-(trifluoromethoxy)phenoxy]piperidin-1-yl}phenoxy)methyl]-2,3-dihydroimidazo[2,1-b]oxazole
|
|
Formula
|
C₂₅H₂₅F₃N₄O₆
|
|
Permeability
|
Cell-permeable
|
